{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:51:52Z","timestamp":1793886712768,"version":"4.8.0"},"reference-count":36,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Endocrinology"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To evaluate (1) the metabolic and endocrine effects of metformin combined with exenatide versus only metformin treatments in patients with polycystic ovary syndrome (PCOS) and abdominal obesity (AO) and (2) to determine the molecular mechanisms by which the combined treatment acts on PCOS patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Randomized controlled trial of PCOS patients with AO to receive combined treatment with metformin\u2013exenatide or metformin alone, and network pharmacology of gene expression in PCOS patients under the combined exposure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>Tertiary teaching hospital.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients:<\/jats:title>\n                    <jats:p>Women with PCOS and AO who fulfilled the Rotterdam Criteria under combined treatment with daily cyclical ethinylestradiol (35\u2009\u03bcg\/day) and cyproterone acetate (2\u2009mg\/day).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention:<\/jats:title>\n                    <jats:p>\n                      Patients were randomized to either combined oral metformin (1500\u2009mg\/day) and exenatide (2\u2009mg weekly subcutaneous injection,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200935 women) treatment or metformin alone (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200931 women) for 12\u2009weeks. Network pharmacological prediction of gene expression under the combined exposure was studied.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures:<\/jats:title>\n                    <jats:p>(1) Basal and after both treatments anthropometric, endocrine, and metabolic changes were compared. (2) Network pharmacological prediction and gene expression were studied in patients under metformin\u2013exenatide treatment. Venn diagram and Markov Cluster Algorithm diagram of core targets for AO were applied to identify key targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Both treatments displayed (1) reductions of total testosterone, insulin, and lipoprotein levels and (2) increases of high-density lipoprotein cholesterol and apolipoprotein A1. We identified PCOS, AO, and comorbid genes further intersected with 269 combination therapy genes. Network pharmacology identified 154 key PCOS genes for drug regulation, including 29 closely related to AO and metabolism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Both treatments improved glucose and lipid metabolism, weakening insulin resistance and improving some biochemical indexes. Network pharmacology identified genes related to AO and metabolism in patients with PCOS under the metformin\u2013exenatide treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration:<\/jats:title>\n                    <jats:p>ClinicalTrials.gov NCT04029272.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20420188251355411","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T11:46:52Z","timestamp":1755604012000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Combined metformin and exenatide versus only metformin treatments in polycystic ovary syndrome with abdominal obesity and network pharmacology of gene expression: evidence from a randomized clinical trial"],"prefix":"10.1177","volume":"16","author":[{"given":"Ding","family":"Xuesong","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric &amp; Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric &amp; Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Weilu","sequence":"additional","affiliation":[{"name":"School of Chinese Medicine, Beijing University of Traditional Chinese Medicine, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric &amp; Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric &amp; Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deng","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric &amp; Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Yanfang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric &amp; Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma","family":"Ruilin","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Qilu Hospital of Shandong University, Jinan, Shandong, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Yingying","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric &amp; Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric &amp; Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faustino R.","family":"P\u00e9rez-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Arag\u00f3n Health Research Institute, University of Zaragoza Faculty of Medicine, Zaragoza, Arag\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric and Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2018.24"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2024.2359031"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2024.02.008"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.17925\/EE.2023.19.1.71"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.04.040"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.147796"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-021-00718-5"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1097706"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-021-04042-6"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.945609"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-023-01285-x"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/4288004"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000001712"},{"key":"e_1_3_3_15_2","unstructured":"Human Gene Database GeneCards (version 4.8.0) http:\/\/www.genecards.org\/"},{"issue":"1","key":"e_1_3_3_16_2","first-page":"145","article-title":"Protein complexes based on topology potential weight in dynamic protein-protein interaction networks","volume":"46","author":"Lei XJ","year":"2018","unstructured":"Lei XJ, Gao Y, Guo L. Protein complexes based on topology potential weight in dynamic protein-protein interaction networks. Acta Electr Sin 2018; 46(1): 145\u2013151.","journal-title":"Acta Electr Sin"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.4103\/wjtcm.wjtcm_11_21"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-021-04042-6"},{"key":"e_1_3_3_19_2","unstructured":"Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses https:\/\/www.genome.jp\/kegg\/"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/13625187.2017.1317735"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad465"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2017.1292125"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa692"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-018-4762-0"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14056"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0115"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa692"},{"issue":"4","key":"e_1_3_3_28_2","first-page":"119","article-title":"Weight change and androgen levels during contraceptive treatment of women affected by polycystic ovary","volume":"40","author":"Vrbikova J","year":"2006","unstructured":"Vrbikova J, Dvorakova K, Hill M, et al. Weight change and androgen levels during contraceptive treatment of women affected by polycystic ovary. Endocr Regul 2006; 40(4): 119\u2013123.","journal-title":"Endocr Regul"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.4149\/gpb_2018049"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-021-00706-3"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2018.03.079"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1434"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202202103R"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.2174\/1386207325666220404101009"},{"issue":"8","key":"e_1_3_3_35_2","first-page":"3255","article-title":"Identification of key genes and molecular pathways in type 2 diabetes mellitus and polycystic ovary syndrome via bioinformatics analyses","volume":"27","author":"Zhang J","year":"2023","unstructured":"Zhang J, Zhang FJ, Zhang L, et al. Identification of key genes and molecular pathways in type 2 diabetes mellitus and polycystic ovary syndrome via bioinformatics analyses. Eur Rev Med Pharmacol Sci 2023; 27(8): 3255\u20133269.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-020-00375-4"},{"key":"e_1_3_3_37_2","volume-title":"National Research Council (US) Panel on Race, ethnicity, and health in laterlife: understanding racial and ethnic differences in health in late life","author":"Bulatao R","year":"2004","unstructured":"Bulatao R, Anderson NB. National Research Council (US) Panel on Race, ethnicity, and health in laterlife: understanding racial and ethnic differences in health in late life. Washington, DC: National Academies Press (US), 2004."}],"container-title":["Therapeutic Advances in Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20420188251355411","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20420188251355411","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20420188251355411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:36:56Z","timestamp":1777592216000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20420188251355411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":36,"alternative-id":["10.1177\/20420188251355411"],"URL":"https:\/\/doi.org\/10.1177\/20420188251355411","relation":{},"ISSN":["2042-0188","2042-0196"],"issn-type":[{"value":"2042-0188","type":"print"},{"value":"2042-0196","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]},"article-number":"20420188251355411"}}